Laboratory aspects of tick-borne diseases: lyme, human granulocytic ehrlichiosis and babesiosis.
Lyme disease, human granulocytic ehrlichiosis (HGE) and babesiosis are emerging infections in the northeastern and midwestern United States, where Ixodes scapularis ticks are prevalent. Lyme disease and babesiosis have also been reported on the West Coast, but less frequently. Lyme disease presents frequently with a skin lesion known as erythema migrans (EM), and diagnostic tests are not necessary if the lesion is classical. Those patients presenting without EM or with atypical skin lesions may need laboratory confirmation. The most frequently used laboratory modality consists of the 2-step serological assays, employing a sensitive ELISA as a first step, followed by IgG and/or IgM immunoblots. Current guidelines for interpretation are those recommended by the CDC. HGE and babesiosis are febrile illnesses with non-specific signs and symptoms. Both infections may present with routine laboratory abnormalities, including leukopenia and/or thrombocytopenia in HGE and anemia in babesiosis. Moderate elevations of liver enzymes may occur in all three tick-borne infections. Specific diagnostic modalities for acute-phase HGE include buffy coat smear examination, culture and PCR. Culture appears to have the greatest sensitivity of the three tests. Babesiosis can be diagnosed by peripheral blood examination for the intraerythrocytic parasites, PCR or serology. Co-infections with these agents exist, but they should be documented by detection of the organisms rather than by serology, since seroprevalence rates are high in endemic areas.
Aguero-Rosenfeld
Marie E
ME
Clinical Laboratories, Room 1J-11a, Westchester Medical Center, Valhalla, NY 10595, USA. m_aguero-rosenfeld@nymc.edu
D000818:Animals; D001404:Babesiosis / Q000175:diagnosis* / Q000453:epidemiology / Q000382:microbiology; D019411:Clinical Laboratory Techniques; D016873:Ehrlichiosis / Q000175:diagnosis* / Q000453:epidemiology / Q000382:microbiology; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D008193:Lyme Disease / Q000175:diagnosis* / Q000453:epidemiology / Q000382:microbiology; D016133:Polymerase Chain Reaction; D017282:Tick-Borne Diseases / Q000175:diagnosis* / Q000453:epidemiology / Q000382:microbiology; D014481:United States / Q000453:epidemiology